Literature DB >> 11762347

Expression of neuropeptide Y receptors in human prostate cancer cells.

P Magni1, M Motta.   

Abstract

BACKGROUND: Neuroendocrine molecules are now believed to play a significant role in the progression of human prostate cancer (CaP), especially in the androgen-independent stage.
MATERIALS AND METHODS: In the present study, we evaluated the presence and the function of the receptors for neuropeptide Y (NPY) in human CaP cell lines (the androgen-dependent LNCaP, and the androgen-independent DU 145 and PC-3).
RESULTS: The presence of high-affinity binding sites for NPY was shown on PC-3 cells (radioreceptor assay). Reverse transcription-polymerase chain reaction analysis indicated that these sites correspond to the Y1 and Y2 receptor isoforms. A Y1 receptor protein (70 kDa) was also detected in PC-3 cell extracts by Western blot analysis. The activation of these receptors by NPY resulted in a reduction of forskolin-induced cAMP accumulation and an increase of [Ca2+]i. Moreover, a prolonged treatment with NPY induced a dose-related proliferation of PC-3 cells.
CONCLUSIONS: By showing that NPY receptors are expressed in the androgen-independent cell line PC-3 and that their activation results in cell proliferation, the present date suggest that NPY-related mechanisms might be relevant in certain stages of CaP, such as the progression of the disease during the androgen-independent stage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11762347     DOI: 10.1093/annonc/12.suppl_2.s27

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  12 in total

1.  Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.

Authors:  Susana Galli; Arlene Naranjo; Collin Van Ryn; Jason U Tilan; Emily Trinh; Chao Yang; Jessica Tsuei; Sung-Hyeok Hong; Hongkun Wang; Ewa Izycka-Swieszewska; Yi-Chien Lee; Olga C Rodriguez; Chris Albanese; Joanna Kitlinska
Journal:  Am J Pathol       Date:  2016-10-12       Impact factor: 4.307

2.  Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development.

Authors:  Sen Mun Wai; Pawel M Kindler; Edward T K Lam; Aiqun Zhang; David T Yew
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

3.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

4.  Heterobivalent dual-target probe for targeting GRP and Y1 receptors on tumor cells.

Authors:  Ajay Shrivastava; Shu-Huei Wang; Natarajan Raju; Izabela Gierach; Haiming Ding; Michael F Tweedle
Journal:  Bioorg Med Chem Lett       Date:  2012-12-05       Impact factor: 2.823

Review 5.  Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.

Authors:  Jason Tilan; Joanna Kitlinska
Journal:  Neuropeptides       Date:  2015-10-26       Impact factor: 3.286

6.  The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.

Authors:  Martin Memminger; Max Keller; Miroslaw Lopuch; Nathalie Pop; Günther Bernhardt; Erwin von Angerer; Armin Buschauer
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Expression of neuropeptide Y is increased in an activated human HSC cell line.

Authors:  Wufei Dai; Yang Liu; Yali Zhang; Yufeng Sun; Changjiang Sun; Yu Zhang; Xiufang Lv
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

Review 8.  Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms.

Authors:  William Butler; Jiaoti Huang
Journal:  Precis Clin Med       Date:  2021-01-28

9.  Genome-wide association analysis reveals regulation of at-risk loci by DNA methylation in prostate cancer.

Authors:  Qiang Liu; Gang Liu; Darryl T Martin; Yu-Tong Xing; Robert M Weiss; Jun Qi; Jian Kang
Journal:  Asian J Androl       Date:  2021 Sep-Oct       Impact factor: 3.285

10.  Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance.

Authors:  Yi Ding; MinJae Lee; Yan Gao; Ping Bu; Christian Coarfa; Brian Miles; Arun Sreekumar; Chad J Creighton; Gustavo Ayala
Journal:  Prostate       Date:  2020-10-06       Impact factor: 4.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.